CF PharmTech

OverviewSuggest Edit

CF PharmTech, Inc. is a specialty pharmaceutical company focused on the development and manufacturing of inhalation products including HFA-based metered dose inhalers, nasal spray, nebulized and dry powder products for respiratory diseases. The company was managed by a caliber of the scientists and executives with 50-year group experiences in American pharmaceutical industry. The company is striving to make medicines better and cheaper for global market.

TypePrivate
Founded2007
HQSuzhou Shi, CN
Websitecfpharmtech.com

Latest Updates

Employees (est.) (Jan 2020)24(-7%)

CF PharmTech Office Locations

CF PharmTech has offices in Suzhou Shi, Wuxi Shi and City of Industry
Suzhou Shi, CN (HQ)
Hu Cun Dang Lu, Xiangcheng Qu
Wuxi Shi, CN
99 Jinxi Rd, Binhu Qu
City of Industry, US
16714 E Johnson Dr
Show all (3)

CF PharmTech Financials and Metrics

Summary Metrics

Founding Date

2007

CF PharmTech total Funding

$155.4 m

CF PharmTech latest funding size

$90.44 m

Time since last funding

23 days ago

CF PharmTech investors

CF PharmTech's latest funding round in January 2020 was reported to be $90.4 m. In total, CF PharmTech has raised $155.4 m
Show all financial metrics

CF PharmTech Operating Metrics

Jan, 2020

Products

20
Show all operating metrics

CF PharmTech Online and Social Media Presence

Embed Graph

CF PharmTech News and Updates

pinned

CF PharmTech Raises $65M in Series D Financing

CF PharmTech Raises $65M in Series D FinancingCF PharmTech, Inc., a Suzhou, China-based specialty pharmaceutical company that develops and manufactures inhalation products, raised $65M in Series D financing.

CF PharmTech beendet Finanzierungsrunde über 90 Mio. USD, will globale Entwicklung von Atemwegsmedikamenten vorantreiben

SHUZHOU, China, 2. Januar 2020 /PRNewswire/ -- CF PharmTech, Inc., ein Pharmaunternehmen, das weltweit hochqualitative und bezahlbare Atemwegsmedikamente vertreibt, hat in einer von New Alliance Capital angeführten Serie-E-Finanzierungsrunde insgesamt 90 Mio. USD mobilisiert. An der...

A CF PharmTech alcança rodada de financiamento de US$ 90 milhões para acelerar o desenvolvimento global de medicamentos para o sistema respiratório

SHUZHOU, China, 2 de janeiro de 2020 /PRNewswire/ -- A CF PharmTech, Inc., uma empresa farmacêutica que visa fornecer medicamentos de qualidade e acessíveis para o sistema respiratório em todo o mundo, anunciou que levantou um investimento de US$ 90 milhões da Série E liderado pela New...

CF PharmTech conclut une ronde de financement de 90 millions de dollars visant à accélérer le développement mondial de médicaments pour les maladies respiratoires

SHUZHOU, Chine, 2 janvier 2020 /PRNewswire/ -- CF PharmTech, Inc., une société pharmaceutique qui se consacre à apporter des médicaments de qualité et abordables pour les maladies respiratoires à l'échelle mondiale, a annoncé avoir levé un investissement de 90 millions de dollars US de...

China’s CF PharmTech raises $90m Series E led by New Alliance Capital

This investment will allow CF PharmTech to bring products in its pipeline to market. The post China’s CF PharmTech raises $90m Series E led by New Alliance Capital appeared first on DealStreetAsia.

CF PharmTech Frequently Asked Questions

  • When was CF PharmTech founded?

    CF PharmTech was founded in 2007.

  • How many employees does CF PharmTech have?

    CF PharmTech has 24 employees.

  • Who are CF PharmTech competitors?

    Competitors of CF PharmTech include Alnylam Pharmaceuticals, Antipodean Pharmaceuticals and AbbVie.

  • Where is CF PharmTech headquarters?

    CF PharmTech headquarters is located at Hu Cun Dang Lu, Xiangcheng Qu, Suzhou Shi.

  • Where are CF PharmTech offices?

    CF PharmTech has offices in Suzhou Shi, Wuxi Shi and City of Industry.

  • How many offices does CF PharmTech have?

    CF PharmTech has 3 offices.